Vischer with Blue Owl on loan facility to Madrigal

Vischer advised globally active asset manager Blue Owl on an up to USD 500 million term loan facility for Madrigal Pharmaceuticals, a biopharmaceutical company specialised in therapeutics for metabolic dysfunction-associated steatohepatitis.

The Vischer team

Adrian Dörig (pictured) led the Vischer team on the matter, working alongside Christian Schneiter and Balthasar Müller (all financing) as well as Christoph Niederer (tax).

flavio.caci@lcpublishinggroup.com

SHARE